DCT

1:23-cv-00715

Boehringer Ingelheim Pharma Inc v. Anobri Pharma US LLC

Log In
General
Filed
06/30/23
Cause of ActionPatent Infringement
SectorTransport., E-Comm.
StatusClosed
Patent Owner
Operating Company
PACER
1:23-cv-00715
Nature of Suit835 ANDA
CourtD. Delaware
Judge
Period
PO Win Rate
William C. Bryson
07/10/23 - 09/25/23
24%
Gregory B. Williams
07/05/23 - 07/10/23
48%
Plaintiff
Party
Name
Ratings
Boehringer-Ingelheim Pharmaceuticals Inc 
L3
A
Boehringer Ingelheim Intl GmbH 
L3
A
No Parties
Attorney
Name
Ratings
Morris Nichols Arsht & Tunnell LLPLocal
L5
A
Jack B. Blumenfeld
L5
A
Anthony D. Raucci
L4
A
Covington & Burling LLP
L4
B
Christopher N. Sipes
L5
E
R. Jason Fowler
L3
E
No Attorneys
Defendant
Party
Name
Ratings
Anobri Pharmaceuticals US LLC 
--
--
--
Shanghai Anovent Pharmaceutical Co Ltd 
--
--
--
NanChang Anovent Pharmaceutical Co Ltd 
--
--
--
No Parties
Attorney
Name
Ratings
No Defendant Attorneys
No Attorneys